Global Ofatumumab Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Report ID: GIR2211160001 | Category: Pharma & Healthcare | Pages: 76 | Format: PDF | Published Date: December 15,2022

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

It is a dosage form administered subcutaneously for the treatment of relapsing forms of multiple sclerosis in adults.
According to our (Global Info Research) latest study, the global Ofatumumab market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Ofatumumab market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2022, are provided.
Key Features:
Global Ofatumumab market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2017-2028
Global Ofatumumab market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2017-2028
Global Ofatumumab market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2017-2028
Global Ofatumumab market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2017-2022
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Ofatumumab
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Ofatumumab market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Glaxosmithkline Inc and Novartis.. etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Ofatumumab market is split by Type and by Application. For the period 2017-2028, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
    20mg/1mL
    20mg/0.4mL
    100mg/5mL
    Others
Market segment by Application
    Relapsing-remitting Multiple Sclerosis
    Clinically Isolated Syndrome
    Active Secondary Progressive Multiple Sclerosis
    Others
Major players covered
    Glaxosmithkline Inc
    Novartis
Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ofatumumab product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Ofatumumab, with price, sales, revenue and global market share of Ofatumumab from 2017 to 2022.
Chapter 3, the Ofatumumab competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ofatumumab breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Ofatumumab market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Ofatumumab.
Chapter 14 and 15, to describe Ofatumumab sales channel, distributors, customers, research findings and conclusion.

1 Market Overview
    1.1 Ofatumumab Introduction
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Ofatumumab Consumption Value by Type: 2017 Versus 2021 Versus 2028
        1.3.2 20mg/1mL
        1.3.3 20mg/0.4mL
        1.3.4 100mg/5mL
        1.3.5 Others
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Ofatumumab Consumption Value by Application: 2017 Versus 2021 Versus 2028
        1.4.2 Relapsing-remitting Multiple Sclerosis
        1.4.3 Clinically Isolated Syndrome
        1.4.4 Active Secondary Progressive Multiple Sclerosis
        1.4.5 Others
    1.5 Global Ofatumumab Market Size & Forecast
        1.5.1 Global Ofatumumab Consumption Value (2017 & 2021 & 2028)
        1.5.2 Global Ofatumumab Sales Quantity (2017-2028)
        1.5.3 Global Ofatumumab Average Price (2017-2028) 
2 Manufacturers Profiles
    2.1 Glaxosmithkline Inc
        2.1.1 Glaxosmithkline Inc Details
        2.1.2 Glaxosmithkline Inc Major Business
        2.1.3 Glaxosmithkline Inc Ofatumumab Product and Services
        2.1.4 Glaxosmithkline Inc Ofatumumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
        2.1.5 Glaxosmithkline Inc Recent Developments/Updates
    2.2 Novartis
        2.2.1 Novartis Details
        2.2.2 Novartis Major Business
        2.2.3 Novartis Ofatumumab Product and Services
        2.2.4 Novartis Ofatumumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
        2.2.5 Novartis Recent Developments/Updates
3 Competitive Environment: Ofatumumab by Manufacturer
    3.1 Global Ofatumumab Sales Quantity by Manufacturer (2017-2022)
    3.2 Global Ofatumumab Revenue by Manufacturer (2017-2022)
    3.3 Global Ofatumumab Average Price by Manufacturer (2017-2022)
    3.4 Market Share Analysis (2021)
        3.4.1 Producer Shipments of Ofatumumab by Manufacturer Revenue ($MM) and Market Share (%): 2021
        3.4.2 Top 3 Ofatumumab Manufacturer Market Share in 2021
        3.4.2 Top 6 Ofatumumab Manufacturer Market Share in 2021
    3.5 Ofatumumab Market: Overall Company Footprint Analysis
        3.5.1 Ofatumumab Market: Region Footprint
        3.5.2 Ofatumumab Market: Company Product Type Footprint
        3.5.3 Ofatumumab Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
    4.1 Global Ofatumumab Market Size by Region
        4.1.1 Global Ofatumumab Sales Quantity by Region (2017-2028)
        4.1.2 Global Ofatumumab Consumption Value by Region (2017-2028)
        4.1.3 Global Ofatumumab Average Price by Region (2017-2028)
    4.2 North America Ofatumumab Consumption Value (2017-2028)
    4.3 Europe Ofatumumab Consumption Value (2017-2028)
    4.4 Asia-Pacific Ofatumumab Consumption Value (2017-2028)
    4.5 South America Ofatumumab Consumption Value (2017-2028)
    4.6 Middle East and Africa Ofatumumab Consumption Value (2017-2028)
5 Market Segment by Type
    5.1 Global Ofatumumab Sales Quantity by Type (2017-2028)
    5.2 Global Ofatumumab Consumption Value by Type (2017-2028)
    5.3 Global Ofatumumab Average Price by Type (2017-2028)
6 Market Segment by Application
    6.1 Global Ofatumumab Sales Quantity by Application (2017-2028)
    6.2 Global Ofatumumab Consumption Value by Application (2017-2028)
    6.3 Global Ofatumumab Average Price by Application (2017-2028)
7 North America
    7.1 North America Ofatumumab Sales Quantity by Type (2017-2028)
    7.2 North America Ofatumumab Sales Quantity by Application (2017-2028)
    7.3 North America Ofatumumab Market Size by Country
        7.3.1 North America Ofatumumab Sales Quantity by Country (2017-2028)
        7.3.2 North America Ofatumumab Consumption Value by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe
    8.1 Europe Ofatumumab Sales Quantity by Type (2017-2028)
    8.2 Europe Ofatumumab Sales Quantity by Application (2017-2028)
    8.3 Europe Ofatumumab Market Size by Country
        8.3.1 Europe Ofatumumab Sales Quantity by Country (2017-2028)
        8.3.2 Europe Ofatumumab Consumption Value by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific
    9.1 Asia-Pacific Ofatumumab Sales Quantity by Type (2017-2028)
    9.2 Asia-Pacific Ofatumumab Sales Quantity by Application (2017-2028)
    9.3 Asia-Pacific Ofatumumab Market Size by Region
        9.3.1 Asia-Pacific Ofatumumab Sales Quantity by Region (2017-2028)
        9.3.2 Asia-Pacific Ofatumumab Consumption Value by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America
    10.1 South America Ofatumumab Sales Quantity by Type (2017-2028)
    10.2 South America Ofatumumab Sales Quantity by Application (2017-2028)
    10.3 South America Ofatumumab Market Size by Country
        10.3.1 South America Ofatumumab Sales Quantity by Country (2017-2028)
        10.3.2 South America Ofatumumab Consumption Value by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa
    11.1 Middle East & Africa Ofatumumab Sales Quantity by Type (2017-2028)
    11.2 Middle East & Africa Ofatumumab Sales Quantity by Application (2017-2028)
    11.3 Middle East & Africa Ofatumumab Market Size by Country
        11.3.1 Middle East & Africa Ofatumumab Sales Quantity by Country (2017-2028)
        11.3.2 Middle East & Africa Ofatumumab Consumption Value by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Market Dynamics
    12.1 Ofatumumab Market Drivers
    12.2 Ofatumumab Market Restraints
    12.3 Ofatumumab Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
    13.1 Raw Material of Ofatumumab and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Ofatumumab
    13.3 Ofatumumab Production Process
    13.4 Ofatumumab Industrial Chain
14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Ofatumumab Typical Distributors
    14.3 Ofatumumab Typical Customers
15 Research Findings and Conclusion
16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Ofatumumab Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?